Research map: Retrospective study on regional nodal irradiation after omission of axillary lymph node dissection in sentinel lymph node-positive breast cancer: a propensity score matching analysis

Back to the article

Papers in this map

  1. Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis · Armando E. Giuliano · 2011 · 2967 citations · Cited by this paper
  2. Ultrasound-Guided Axillary Management in Early-Stage Breast Cancer: From Diagnosis to De-Escalation · Xiangmin Shen · 2026 · Cites this paper
  3. Factors influencing discussion duration in breast cancer multidisciplinary team meetings: insights for streamlining care · 2026 · Related
  4. Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer · Armando E. Giuliano · 1994 · 2924 citations · Cited by this paper
  5. Antacid co-treatment and pregnane X receptor genetic polymorphisms are survival determinants in patients treated with palbociclib · 2026 · Related
  6. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials · EBCTCG (Early Breast Cancer Trialists' Collaborative Group) · 2014 · 2298 citations · Cited by this paper
  7. Curative-intent stereotactic ablative body radiation, surgery, and systemic therapy in non-osseous oligometastatic breast cancer · 2026 · Related
  8. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis · Armando E. Giuliano · 2017 · 1942 citations · Cited by this paper
  9. Early first-line systemic anticancer therapeutic attrition after metastatic recurrence in triple-negative breast cancer following neoadjuvant chemo-immunotherapy: a multicenter real-world study · 2026 · Related
  10. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial · Mila Donker · 2014 · 1893 citations · Cited by this paper
  11. Abemaciclib rechallenge after progression on abemaciclib plus endocrine therapy in patients with hormone receptor-positive HER2-negative metastatic breast cancer: results from the phase II again study (WJOG14220B) · 2026 · Related
  12. Regional Nodal Irradiation in Early-Stage Breast Cancer · Timothy Joseph Whelan · 2015 · 1325 citations · Cited by this paper
  13. Age-stratified difference in patient-reported health-related quality of life following breast cancer surgery · 2026 · Related
  14. A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy · Kimberly J. Van Zee · 2003 · 824 citations · Cited by this paper
  15. Rediscovering the Ciucci pathway: in-vivo evidence of a palmar lymphatic channel · 2026 · Related
  16. Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology · William John Gradishar · 2024 · 655 citations · Cited by this paper
  17. Clinical implications of discordance in HER2 reassessment from HercepTest to 4B5 in metastatic breast cancer · 2026 · Related
  18. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial · Viviana Enrica Galimberti · 2018 · 589 citations · Cited by this paper
  19. Impact of axillary surgery on survival in de novo metastatic breast cancer with primary tumor resection · 2026 · Related
  20. Radiation Field Design in the ACOSOG Z0011 (Alliance) Trial · Reshma Jagsi · 2014 · 396 citations · Cited by this paper
  21. Comments on: Cost-effectiveness of DPYD genotyping prior to capecitabine administration for metastatic breast cancer · 2026 · Related
  22. Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial · Sanne A. L. Bartels · 2022 · 389 citations · Cited by this paper
  23. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla – Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer · Ákos Sávolt · 2017 · 340 citations · Cited by this paper
  24. Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases · Jana de Boniface · 2024 · 303 citations · Cited by this paper
  25. Internal mammary and medial supraclavicular lymph node chain irradiation in stage I–III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial · Philip M. Poortmans · 2020 · 302 citations · Cited by this paper
  26. Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023 · Giuseppe Curigliano · 2023 · 243 citations · Cited by this paper
  27. Predicting Nonsentinel Node Status After Positive Sentinel Lymph Biopsy for Breast Cancer: Clinicians Versus Nomogram · Michelle Connolly Specht · 2005 · 231 citations · Cited by this paper
  28. Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1–2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial · Corrado Tinterri · 2022 · 163 citations · Cited by this paper
  29. POSNOC—POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes · Amit Goyal · 2021 · 92 citations · Cited by this paper
  30. Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy · Elizabeth FitzSullivan · 2016 · 75 citations · Cited by this paper
  31. Trends on Axillary Surgery in Nondistant Metastatic Breast Cancer Patients Treated Between 2011 and 2015 · Ingrid G. M. Poodt · 2017 · 71 citations · Cited by this paper
  32. Trends in axillary lymph node dissection for early-stage breast cancer in Europe: Impact of evidence on practice · Carlos A. Garcia‐Etienne · 2019 · 45 citations · Cited by this paper
  33. Omission of axillary lymph node dissection in patients who underwent total mastectomy with 1 or 2 metastatic lymph nodes · Bong Kyun Kim · 2020 · 26 citations · Cited by this paper
  34. Axilla lymph node dissection can be safely omitted in patients with 1–2 positive sentinel nodes receiving mastectomy: a large multi-institutional study and a systemic meta-analysis · Weiqi Gao · 2022 · 26 citations · Cited by this paper
  35. Development and external validation of a nomogram to predict four or more positive nodes in breast cancer patients with one to three positive sentinel lymph nodes · Zhuanbo Yang · 2020 · 25 citations · Cited by this paper
  36. Protocol for the T-REX-trial: tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases – an open, multicentre, randomised non-inferiority phase 3 trial · Sara Alkner · 2023 · 21 citations · Cited by this paper
  37. Development and Validation of an Intraoperative Nomogram to Predict Breast Cancer-Related Lymphedema Based on the Arm Lymphatics Distribution · Qianqian Yuan · 2021 · 15 citations · Cited by this paper
  38. Association Between Regional Nodal Irradiation and Breast Cancer Recurrence-Free Interval for Patients With Low-Risk, Node-Positive Breast Cancer · Daegan Sit · 2021 · 7 citations · Cited by this paper
  39. Can axillary lymph node dissection be omitted in breast cancer patients with 1-2 positive sentinel nodes? A systematic review and meta-analysis · Jinyi Xie · 2025 · 2 citations · Cited by this paper

Source: OpenAlex (CC0)